Fast Track Donor Leverage AllCells' Pre-Characterized Donor Selection Program to offer clients accelerated donor screening and collection for clinical manufacturing. Highlight regulatory readiness—FDA-registered donor facilities, IRB approvals, and AABB compliance—to reduce time-to-therapy for CGT developers and CROs.

Regional Expansion Explain how new Houston and Huntsville centers enable regional sourcing and faster delivery of starting materials, cutting transit risk for customers in Texas and the Southeast. Use expanded network to upsell donor management, processing, and analytical services.

Regulatory Edge Promote the fully compliant donor ecosystem as a risk mitigation differentiator for regulated therapies, emphasizing FDA-registered facilities, IRB oversight, and AABB alignment to support GMP-grade starting materials and long-term supply agreements.

GMP Leukopaks Highlight GMP-compliant cryopreserved leukopaks as a high-demand starting material, offering bundled solutions with donor characterization and analytical capabilities to streamline clinical manufacturing and scale.

Integrated Partner Position AllCells as a one-stop supplier for clinical-grade and RUO products, donor management, and analytics to reduce vendor fragmentation for CGT programs, while signaling stability and scale from its Discovery Life Sciences backing.